Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Retained Earnings (2023 - 2025)

Historic Retained Earnings for Beta Bionics (BBNX) over the last 3 years, with Q3 2025 value amounting to -$356.5 million.

  • Beta Bionics' Retained Earnings changed N/A to -$356.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$356.5 million, marking a year-over-year change of. This contributed to the annual value of -$296.7 million for FY2024, which is 2920.48% down from last year.
  • Per Beta Bionics' latest filing, its Retained Earnings stood at -$356.5 million for Q3 2025.
  • Over the past 5 years, Beta Bionics' Retained Earnings peaked at -$229.7 million during Q4 2023, and registered a low of -$356.5 million during Q3 2025.
  • Over the past 3 years, Beta Bionics' median Retained Earnings value was -$325.4 million (recorded in 2025), while the average stood at -$310.1 million.
  • The largest annual percentage gain for Beta Bionics' Retained Earnings in the last 5 years was 2920.48% (2024), contrasted with its biggest fall of 2920.48% (2024).
  • Quarter analysis of 3 years shows Beta Bionics' Retained Earnings stood at -$229.7 million in 2023, then dropped by 29.2% to -$296.7 million in 2024, then dropped by 20.13% to -$356.5 million in 2025.
  • Its Retained Earnings stands at -$356.5 million for Q3 2025, versus -$342.3 million for Q2 2025 and -$325.4 million for Q1 2025.